Inoviq
Inoviq is an Australian biotechnology company focused on developing and commercializing innovative cancer diagnostic products. The company's focus is on improving cancer detection and monitoring through its proprietary technologies. Inoviq aims to address unmet needs in cancer diagnostics, offering potential benefits for patients and healthcare providers.
Short position
Inoviq (ASX:IIQ) has 0.00% of its shares on issue reported as short positions as of 5 Oct 2026, or about 27 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.58% in October 2025. IIQ is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4IIQ community
Research Threads
Bull, bear, catalyst, and news-reaction posts tied directly to IIQ.
Start the first IIQ research thread
Anchor the conversation with a thesis, a catalyst, or a question worth debating.